February 19, 2019 – The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. The Task Force found that testing is beneficial for the small number of women in the United States who are at increased risk for BRCA1 or BRCA2 mutations. The draft recommendation statement and draft evidence review are available for review and public comment from February 19, 2019 to March 18, 2019 here.
